Subtopic Deep Dive
Cervical Cancer Epidemiology
Research Guide
What is Cervical Cancer Epidemiology?
Cervical Cancer Epidemiology studies the global incidence, mortality trends, and risk factors of cervical cancer using population-based registry data and modeling techniques.
Researchers analyze data from GLOBOCAN databases to estimate burden, with HPV as the primary cause. Key papers include Jemal et al. (2011) with 54,947 citations on global cancer statistics and de Martel et al. (2017) with 2,188 citations quantifying HPV-attributable cervical cancer worldwide. Over 10 major papers from 2002-2024 provide incidence data across 180+ countries.
Why It Matters
Epidemiological data from Jemal et al. (2011) and Bray et al. (2005) guide WHO vaccination programs, targeting HPV types 16/18 responsible for 70% of cases per Clifford et al. (2003). de Martel et al. (2017) models show 630,000 new HPV-related cancers yearly, prioritizing screening in low-resource areas like sub-Saharan Africa where incidence exceeds 30/100,000 women. Plummer et al. (2016) infection-attributable estimates inform $10B+ global investments in Cervarix and Gardasil vaccines.
Key Research Challenges
Data Quality Variability
Registry coverage varies, with high-income countries at 95% completeness versus 20% in Africa per Jemal et al. (2011). Modeling imputes missing data using GLOBOCAN methods (Bray et al., 2005). This leads to 15-20% uncertainty in low-burden estimates.
HPV Attribution Modeling
Quantifying HPV fraction requires prevalence surveys; de Martel et al. (2017) used 118 studies for site-specific fractions. Country-level variations challenge global models (Plummer et al., 2016). Type-specific burdens for 16/18 vs. others add complexity (Clifford et al., 2003).
Screening Disparity Analysis
Pap smear and HPV testing uptake differs; Forman et al. (2012) highlight 80% mortality reduction in screened populations. Trends post-vaccination are emerging but lack long-term data (Harper et al., 2006). Regional disparities persist in Asia-Pacific high-incidence zones.
Essential Papers
Global cancer statistics
Ahmedin Jemal, Freddie Bray, Melissa M. Center et al. · 2011 · CA A Cancer Journal for Clinicians · 54.9K citations
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking,...
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · 2005 · CA A Cancer Journal for Clinicians · 18.4K citations
Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year 2002 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The result...
Cancer statistics, 2024
Rebecca L. Siegel, Angela N. Giaquinto, Ahmedin Jemal · 2024 · CA A Cancer Journal for Clinicians · 8.1K citations
Abstract Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and...
Papillomaviruses and cancer: from basic studies to clinical application
Harald zur Hausen · 2002 · Nature reviews. Cancer · 4.0K citations
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel, Martyn Plummer, Jérôme Vignat et al. · 2017 · International Journal of Cancer · 2.2K citations
HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable cancer burden ...
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote et al. · 2020 · International Journal of Gynecological Cancer · 1.8K citations
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · 2006 · The Lancet · 1.6K citations
Reading Guide
Foundational Papers
Start with Jemal et al. (2011) for GLOBOCAN methodology and global baselines (54,947 cites), then Bray et al. (2005) for 2002 data framework, and zur Hausen (2002) for HPV causation basics.
Recent Advances
Siegel et al. (2024) for US 2024 stats (8,145 cites); de Martel et al. (2017) for HPV-attributable modeling; Plummer et al. (2016) for infection fractions.
Core Methods
GLOBOCAN incidence estimation via registries and imputation (Ferlay methods); HPV fraction calculation from surveys (de Martel); type distribution meta-analysis (Clifford); burden modeling with Joinpoint trends.
How PapersFlow Helps You Research Cervical Cancer Epidemiology
Discover & Search
Research Agent uses searchPapers('cervical cancer GLOBOCAN incidence') to retrieve Jemal et al. (2011, 54,947 citations), then citationGraph reveals de Martel et al. (2017) connections, and findSimilarPapers expands to Plummer et al. (2016) for infection-attributable burdens.
Analyze & Verify
Analysis Agent applies readPaperContent on de Martel et al. (2017) to extract HPV fractions by country, verifyResponse with CoVe checks model assumptions against Forman et al. (2012), and runPythonAnalysis plots incidence trends using pandas on GLOBOCAN CSV exports with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in post-2020 screening data via contradiction flagging between Siegel et al. (2024) and older GLOBOCAN; Writing Agent uses latexEditText for methods sections, latexSyncCitations integrates 20+ refs, latexCompile generates figures, and exportMermaid visualizes HPV burden flowcharts.
Use Cases
"Analyze cervical cancer incidence trends 2002-2024 using GLOBOCAN data"
Research Agent → searchPapers → runPythonAnalysis (pandas trend plot on extracted CSV) → matplotlib incidence/mortality graph with R² fit.
"Draft LaTeX review on HPV-attributable cervical cancer burden"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Jemal 2011, de Martel 2017) → latexCompile → PDF with tables.
"Find code for modeling cervical cancer risk factors"
Research Agent → paperExtractUrls (Plummer 2016) → paperFindGithubRepo → githubRepoInspect → Python scripts for Poisson regression on registry data.
Automated Workflows
Deep Research workflow scans 50+ GLOBOCAN papers via searchPapers → citationGraph → structured report with incidence tables by WHO region. DeepScan applies 7-step CoVe to verify de Martel et al. (2017) HPV fractions against Clifford et al. (2003) meta-analysis. Theorizer generates hypotheses on vaccination impact from Harper et al. (2006) to Siegel et al. (2024) trends.
Frequently Asked Questions
What defines Cervical Cancer Epidemiology?
It analyzes global incidence, mortality, and HPV risk factors using registry data like GLOBOCAN (Jemal et al., 2011).
What are core methods?
GLOBOCAN modeling estimates from 4,000 registries; HPV attribution via prevalence surveys (de Martel et al., 2017); meta-analysis of types (Clifford et al., 2003).
What are key papers?
Jemal et al. (2011, 54,947 cites) for global stats; de Martel et al. (2017, 2,188 cites) for HPV burden; Bray et al. (2005, 18,351 cites) for 2002 baselines.
What open problems exist?
Post-vaccination trends in low-coverage areas; real-time modeling amid COVID disruptions; integrating genomics with epidemiology (Plummer et al., 2016 gaps).
Research Cervical Cancer and HPV Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cervical Cancer Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cervical Cancer and HPV Research Research Guide